Skip to main content
. Author manuscript; available in PMC: 2014 Jan 2.
Published in final edited form as: Nat Rev Drug Discov. 2010 Apr;9(4):10.1038/nrd3012. doi: 10.1038/nrd3012

Figure 3. Synthetic glycoconjugate immunogens.

Figure 3

This figure shows examples of synthetic carbohydrate immunogens used in vaccine development. Hib: polyribosylribitol-TT (QuimiHib®); Candida: Man3-TT; Plasmodium: GPI-KLH. HIV: Man9 glycodendron BSA conjugate and Qβ-Man9 (overall representations also depicted), GlcNAc2Man9 divalent glycopeptide OMPC conjugate (outer membrane protein complex, derived from N. meningitidis); Cancer: KLH-Globo H, KLH-clustered Tn, unimolecular pentavalent KLH conjugate.